By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nordic Nanovector 

Kjelsåsveien 168 B

  Oslo  0884  Norway
Phone: 47-22-18-33-01 Fax: 47-22-58-00-07


SEARCH JOBS








Company News
Nordic Nanovector - Results For First Quarter 2017 5/24/2017 8:56:38 AM
Nordic Nanovector Release: Safety Review Committee Approves The Continued Evaluation Of The 20 Mbq/Kg Betalutin With 100 Mg/M2 Lilotomab Regimen In Phase ll Cohort In NHL 5/19/2017 9:32:48 AM
Nordic Nanovector: Invitation To First Quarter 2017 Results Presentation And Webcast 5/16/2017 11:26:59 AM
Nordic Nanovector: Notice Of Annual General Meeting On 24 May 2017 5/2/2017 9:45:27 AM
Nordic Nanovector Release: Updated Results From Phase I/II Trial Of Betalutin In NHL Accepted For Presentation At The International Conference On Malignant Lymphoma In June 4/28/2017 6:34:37 AM
Nordic Nanovector - Financial Calendar 3/27/2017 9:49:45 AM
Nordic Nanovector Publishes Annual Report 2016 3/24/2017 10:41:48 AM
Nordic Nanovector Announces First Patient Dosed In Phase I Study Of Betalutin In Diffuse Large B-Cell Lymphoma (DLBCL), An Aggressive Form Of NHL 3/17/2017 6:30:58 AM
Nordic Nanovector - Results For Fourth Quarter And Full Year 2016 2/28/2017 8:21:55 AM
Nordic Nanovector: Invitation To Fourth Quarter And Full Year 2016 Results Presentation And Webcast 2/22/2017 7:40:52 AM
12345678910...
//-->